Your browser doesn't support javascript.
loading
Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer.
Marmorino, Federica; Salvatore, Lisa; Barbara, Cecilia; Allegrini, Giacomo; Antonuzzo, Lorenzo; Masi, Gianluca; Loupakis, Fotios; Borelli, Beatrice; Chiara, Silvana; Banzi, Maria Chiara; Miraglio, Emanuela; Amoroso, Domenico; Dargenio, Francesco; Bonetti, Andrea; Martignetti, Angelo; Paris, Myriam; Tomcikova, Daniela; Boni, Luca; Falcone, Alfredo; Cremolini, Chiara.
Afiliación
  • Marmorino F; Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Istituto Toscano Tumori, Via Roma, 67, 56126 Pisa, Italy.
  • Salvatore L; Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Istituto Toscano Tumori, Via Roma, 67, 56126 Pisa, Italy.
  • Barbara C; Department of Medical Oncology, Ospedale Civile di Livorno, Viale Alfieri, 36, 57121 Livorno, Italy.
  • Allegrini G; Division of Medical Oncology, Pontedera Hospital, via Taddeo Alderotti, 26, 56025 Pisa, Italy.
  • Antonuzzo L; Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla, 3, 50134 Firenze, Italy.
  • Masi G; Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Istituto Toscano Tumori, Via Roma, 67, 56126 Pisa, Italy.
  • Loupakis F; Istituto Oncologico Venoto, Via Gattamelata, 64, 35128 Padova, Italy.
  • Borelli B; Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Istituto Toscano Tumori, Via Roma, 67, 56126 Pisa, Italy.
  • Chiara S; National Institute for Cancer Research, Largo R. Benzi, 10, 16132 Genova, Italy.
  • Banzi MC; Arcispedale Santa Maria Nuova, IRCCS, Viale Risorgimento, 80, 42123 Reggio Emilia, Italy.
  • Miraglio E; Department of Oncology, S. Croce General Hospital, Via Carle 25, 12100 Cuneo, Italy.
  • Amoroso D; Ospedale Versilia-Lido di Camaiore, Strada Statale 1 Via Aurelia, 335, 55041 Viareggio, Italy.
  • Dargenio F; Dipartimento oncologico AUSL 6 Livorno-Piombino, Via Forlanini, 57025 Piombino, Italy.
  • Bonetti A; Department of Medical Oncology Mater Salutis Hospital Legnago, Via Gianella 1, 37045 Legnago, Italy.
  • Martignetti A; Dipartimento Oncologico AUSL 7, Val d'Elsa, 53036 Poggibonsi, Italy.
  • Paris M; S.O.C. Oncologia-Ospedale degli Infermi, Via Ponderanesi, 2, 13811 Biella, Italy.
  • Tomcikova D; Fondazione Sandro Pitigliani, Via Dolce de Mazzamuti, 7, 59100 Prato, Italy.
  • Boni L; Clinical Trial Coordinating Center, AOU Careggi, Istituto Toscano Tumori, Largo Brambilla, 3, 50134 Firenze, Italy.
  • Falcone A; Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Istituto Toscano Tumori, Via Roma, 67, 56126 Pisa, Italy.
  • Cremolini C; Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Istituto Toscano Tumori, Via Roma, 67, 56126 Pisa, Italy.
Br J Cancer ; 116(3): 318-323, 2017 01.
Article en En | MEDLINE | ID: mdl-28081548
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Adenocarcinoma / Inhibidores de la Angiogénesis / Bevacizumab / L-Lactato Deshidrogenasa Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Adenocarcinoma / Inhibidores de la Angiogénesis / Bevacizumab / L-Lactato Deshidrogenasa Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Italia